# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: Laboratory Criteria

Extent: E+W+S+N.I.

At least one of the following four:
Isolation of rubella virus from a clinical specimen
Detection of rubella virus nucleic acid in a clinical specimen
Rubella IgM antibody detection
Rubella IgG seroconversion or significant rise in rubella IgG antibody titre in paired specimens tested in parallel.
Laboratory results need to be interpreted according to the vaccination status (possible persistence of IgM antibodies upon vaccination).

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.36/division/2 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.36/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.